🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase Ib study investigating whether liposome BLP25 mucin-1 (MUC1) peptide-...
Status
Withdrawn
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT01731587
Treatments Being Tested
To investigate the clinical benefits of Docetaxel or alternating AC-Docetax...
Status
Completed
Location
National Cancer Center Hospital
Start Date
1999-01
Trial ID
NCT00190489
This is a Phase 2b, randomized, open label study to assess the safety and e...
Status
Recruiting
Location
Compassionate Cancer Care Medical Group
Start Date
2021-06-18
Trial ID
NCT04920617
Treatments Being Tested
The purpose of this study is to test a combined treatment using cyclophosph...
Status
Completed
Location
Baylor University Medical Center
Start Date
2006-03
Trial ID
NCT00313235
Treatments Being Tested
This research study is evaluating an investigational drug, an oncolytic vir...
Status
Active Not Recruiting
Location
Johns Hopkins University Medical Center
Start Date
2017-07-18
Trial ID
NCT03152318
Treatments Being Tested
The objective of this mechanistic study is to determine the impact of tecem...
Status
Completed
Location
NKI (Nederlands Kanker Instituut)
Start Date
2012-02
Trial ID
NCT01507103
Treatments Being Tested
To evaluate the safety and tolerability of escalating doses GX-I7 in combin...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2019-03-27
Trial ID
NCT03752723
Treatments Being Tested
The purpose of this study is to compare the genotype-based personal prescri...
Status
Completed
Location
School of Pharmaceutical Sciences Sun Yat-sen University
Start Date
2012-10
Trial ID
NCT01689350
Treatments Being Tested
The purpose of this study is to determine whether the combination of chemot...
Status
Terminated
Location
Baylor University Medical Center
Start Date
2008-06
Trial ID
NCT00722098
Treatments Being Tested
This is a Phase 1b, open label, multi-center study of CMB305 (sequentially ...
Status
Terminated
Location
Sarcoma Oncology Center
Start Date
2015-02-28
Trial ID
NCT02387125
Treatments Being Tested